• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
[Chinese consensus on the diagnosis and management of Epstein-Barr virus-related post-transplant lymphoproliferative disorders after hematopoietic stem cell transplantation (2022)].[造血干细胞移植后EB病毒相关移植后淋巴增殖性疾病诊断和管理的中国专家共识（2022年）]
Zhonghua Xue Ye Xue Za Zhi. 2022 Sep 14;43(9):716-725. doi: 10.3760/cma.j.issn.0253-2727.2022.09.002.
2
[Recent advances on diagnosis and therapy of lymphoproliferative disorders after allo-HSCT].[异基因造血干细胞移植后淋巴增殖性疾病的诊断与治疗新进展]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Apr;22(2):538-42. doi: 10.7534/j.issn.1009-2137.2014.02.051.
3
Epstein-Barr virus post-transplant lymphoproliferative disease (PTLD) after hematopoietic stem cell transplantation.造血干细胞移植后 EBV 相关移植后淋巴增殖性疾病（PTLD）。
Eur J Haematol. 2018 Sep;101(3):283-290. doi: 10.1111/ejh.13131. Epub 2018 Aug 3.
4
Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines.异基因造血干细胞移植后患者的爱泼斯坦-巴尔病毒感染及移植后淋巴增殖性疾病的管理：第六届欧洲白血病感染会议（ECIL-6）指南
Haematologica. 2016 Jul;101(7):803-11. doi: 10.3324/haematol.2016.144428.
5
[Diagnosis and treatment of CMV and EBV Reactivation as well as Post-transplant Lymphoproliferative Disorders following Allogeneic Stem Cell Transplantation: An SFGM-TC report].[异基因造血干细胞移植后巨细胞病毒和EB病毒再激活以及移植后淋巴细胞增殖性疾病的诊断与治疗：SFGM-TC报告]
Pathol Biol (Paris). 2013 Aug;61(4):152-4. doi: 10.1016/j.patbio.2013.07.003. Epub 2013 Sep 4.
6
Epstein-Barr virus-associated leukemic lymphoma after allogeneic stem cell transplantation.异基因造血干细胞移植后 Epstein-Barr 病毒相关白血病淋巴瘤
J Clin Virol. 2016 Jul;80:82-6. doi: 10.1016/j.jcv.2016.04.020. Epub 2016 May 6.
7
Gastrointestinal tract involvement of Epstein-Barr virus-associated post-transplant lymphoproliferative disorder after cord blood transplantation.脐血移植后爱泼斯坦-巴尔病毒相关移植后淋巴增殖性疾病的胃肠道受累情况
Pediatr Int. 2022 Jan;64(1):e15233. doi: 10.1111/ped.15233.
8
Epstein-Barr virus lymphoproliferative disorders after liver transplantation.肝移植后爱泼斯坦-巴尔病毒淋巴增殖性疾病
Clin Liver Dis. 1997 Aug;1(2):453-69, x-xi. doi: 10.1016/s1089-3261(05)70280-4.
9
Differentiating Between Epstein-Barr Virus-positive Lymphoid Neoplasm Relapse and Post-transplant Lymphoproliferative Disorder After Sex-mismatched Hematopoietic Stem Cell Transplantation.区分异基因造血干细胞移植后 EBV 阳性淋巴肿瘤复发与移植物抗宿主病相关淋巴组织增生性疾病。
Am J Surg Pathol. 2024 Apr 1;48(4):395-405. doi: 10.1097/PAS.0000000000002183. Epub 2024 Jan 30.
10
EBV+ posttransplant lymphoproliferative disease of the retina presenting as cytomegalovirus retinitis.表现为巨细胞病毒性视网膜炎的EBV阳性移植后视网膜淋巴组织增生性疾病
Ann Hematol. 2021 Dec;100(12):3061-3063. doi: 10.1007/s00277-020-04292-z. Epub 2020 Oct 3.

引用本文的文献

1
Metachronous spinal cord involvement B cell and subcutaneous tissue involvement NK/T cell lymphoid proliferations and lymphomas arising in post-transplantation mimicking general NK/T cell lymphoma: a case report and review of the literature.移植后发生的类似全身 NK/T 细胞淋巴瘤的脊髓和皮肤 B 细胞及皮下组织 NK/T 细胞淋巴增生和淋巴瘤：病例报告及文献复习。
Front Immunol. 2024 Oct 14;15:1467506. doi: 10.3389/fimmu.2024.1467506. eCollection 2024.
2
[Rituximab based treatment in pediatric Epsstain Bar Virus associated lymphocyte proliferative diseases after aplastic anemia with haplo-identical transplantation:a prospective single centre study].[单倍体相合移植后再生障碍性贫血患儿中基于利妥昔单抗治疗的爱泼斯坦-巴尔病毒相关淋巴细胞增殖性疾病：一项前瞻性单中心研究]
Zhonghua Xue Ye Xue Za Zhi. 2024 Jul 14;45(7):678-682. doi: 10.3760/cma.j.cn121090-20231229-00345.
3
Clinical epidemiology of Epstein-Barr virus-associated Lymphoproliferative Disorders (EBV-LPDs) in hospitalized children: A six-year multi-institutional study in China.中国六年来住院儿童中与 Epstein-Barr 病毒相关的淋巴组织增生性疾病（EBV-LPDs）的临床流行病学研究。
Ital J Pediatr. 2024 Jul 2;50(1):125. doi: 10.1186/s13052-024-01685-y.

本文引用的文献

1
The clinical characteristics and prognosis in adult Ph negative acute lymphoblastic leukemia with TP53 aberrations.伴有TP53畸变的成人Ph阴性急性淋巴细胞白血病的临床特征及预后
Exp Hematol Oncol. 2022 Apr 8;11(1):22. doi: 10.1186/s40164-022-00274-1.
2
Epstein-Barr virus posttransplant lymphoproliferative disorder: update on management and outcomes.移植后 EBV 相关淋巴组织增生性疾病：治疗与结局的最新进展。
Curr Opin Infect Dis. 2021 Dec 1;34(6):635-645. doi: 10.1097/QCO.0000000000000787.
3
Risk Factors for the Incidence of and the Mortality due to Post-Transplant Lymphoproliferative Disorder after Hematopoietic Cell Transplantation.移植后造血细胞移植后发生和死亡的淋巴组织增生性疾病的危险因素。
Transplant Cell Ther. 2022 Jan;28(1):53.e1-53.e10. doi: 10.1016/j.jtct.2021.09.021. Epub 2021 Oct 1.
4
The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update.中华血液学分会关于异基因造血干细胞移植适应证、预处理方案及供者选择的专家共识（2021 年版）
J Hematol Oncol. 2021 Sep 15;14(1):145. doi: 10.1186/s13045-021-01159-2.
5
Allogeneic stem cell transplantation may overcome the adverse impact of myelofibrosis on the prognosis of myelodysplastic syndrome.异基因干细胞移植可能会克服骨髓纤维化对骨髓增生异常综合征预后的不利影响。
Exp Hematol Oncol. 2021 Aug 14;10(1):44. doi: 10.1186/s40164-021-00238-x.
6
Imaging biomarkers for evaluating tumor response: RECIST and beyond.用于评估肿瘤反应的影像生物标志物：RECIST及其他。
Biomark Res. 2021 Jul 2;9(1):52. doi: 10.1186/s40364-021-00306-8.
7
Reduction of immunosuppression combined with whole-brain radiotherapy and concurrent systemic rituximab is an effective yet toxic treatment of primary central nervous system post-transplant lymphoproliferative disorder (pCNS-PTLD): 14 cases from the prospective German PTLD registry.减少免疫抑制联合全脑放疗和同期全身利妥昔单抗治疗原发性中枢神经系统移植后淋巴组织增生性疾病（pCNS-PTLD）：来自前瞻性德国 PTLD 登记处的 14 例病例。
Ann Hematol. 2021 Aug;100(8):2043-2050. doi: 10.1007/s00277-021-04548-2. Epub 2021 May 11.
8
Current and emerging therapies for primary central nervous system lymphoma.原发性中枢神经系统淋巴瘤的现有及新兴疗法。
Biomark Res. 2021 May 6;9(1):32. doi: 10.1186/s40364-021-00282-z.
9
Histological verification of the treatment effect of tirabrutinib for relapsed/refractory primary central nervous system lymphoma.替拉鲁替尼治疗复发/难治性原发性中枢神经系统淋巴瘤疗效的组织学验证
Exp Hematol Oncol. 2021 Apr 26;10(1):29. doi: 10.1186/s40164-021-00222-5.
10
Post-transplantation lymphoproliferative disorder after haematopoietic stem cell transplantation.造血干细胞移植后移植后淋巴组织增生性疾病。
Ann Hematol. 2021 Apr;100(4):865-878. doi: 10.1007/s00277-021-04433-y. Epub 2021 Feb 6.

[Chinese consensus on the diagnosis and management of Epstein-Barr virus-related post-transplant lymphoproliferative disorders after hematopoietic stem cell transplantation (2022)].

出版信息

Zhonghua Xue Ye Xue Za Zhi. 2022 Sep 14;43(9):716-725. doi: 10.3760/cma.j.issn.0253-2727.2022.09.002.

DOI:10.3760/cma.j.issn.0253-2727.2022.09.002
PMID:36709164
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9613495/
Abstract
摘要